Ambey Laboratories IPO vs Nephro Care India IPO

Comparision between Ambey Laboratories IPO and Nephro Care India IPO.

IPO Details

Ambey Laboratories IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Nephro Care India IPO is a SME Book Built Issue proposed to list at NSE SME.

	Ambey Laboratories IPO	Nephro Care India IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	NSE SME	NSE SME
Lead Managers	Fast Track Finsec Pvt Ltd	Corporate Capitalventures Pvt Ltd
Registrar	Link Intime India Private Ltd	Bigshare Services Pvt Ltd
Market Maker	Nikunj Stock Brokers Limited	Ss Corporate Securities Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Nephro Care India IPO is up to ₹41.26 Cr. The final issue price of Ambey Laboratories IPO is and of Nephro Care India IPO is ₹90.00 per share.

	Ambey Laboratories IPO	Nephro Care India IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹65.00 per share	₹85.00 per share
Issue Price (Upper)	₹68.00 per share	₹90.00 per share
Issue Price (Final)		₹90.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	2000 shares	1600 shares
Fresh Issue Size	62,58,000 shares	45,84,000 shares
Fresh Issue Size (Amount)	up to ₹42.55 Cr	up to ₹41.26 Cr
OFS Issue Size	3,12,000 shares
OFS Issue Size (Amount)	up to ₹2.12 Cr
Issue Size Total	65,70,000 shares	45,84,000 shares
Issue Size Total (Amount)	up to ₹44.68 Cr	up to ₹41.26 Cr

IPO Timetable

Ambey Laboratories IPO opens on Jul 04, 2024, while Nephro Care India IPO opens on Jun 28, 2024. The closing date of Ambey Laboratories IPO and Nephro Care India IPO is Jul 08, 2024, and Jul 02, 2024, respectively.

	Ambey Laboratories IPO	Nephro Care India IPO
Anchor Bid Date	Jul 03, 2024	Jun 27, 2024
Issue Open	Jul 04, 2024	Jun 28, 2024
Issue Close	Jul 08, 2024	Jul 02, 2024
Basis Of Allotment (Tentative)	Jul 09, 2024	Jul 03, 2024
Initiation of Refunds (Tentative)	Jul 10, 2024	Jul 04, 2024
Credit of Share (Tentative)	Jul 10, 2024	Jul 04, 2024
Listing date (Tentative)	Jul 11, 2024	Jul 05, 2024
Anchor Lockin End date 1	Aug 08, 2024	Aug 02, 2024
Anchor Lockin End date 2	Oct 07, 2024	Oct 01, 2024

Financials

Ambey Laboratories IPO P/E ratio is 27.81, as compared to Nephro Care India IPO P/E ratio of 55.15.

Ambey Laboratories IPO

Nephro Care India IPO

Financial

Ambey Laboratories Limited Financial Information (Restated)

Period Ended	31 Jan 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	8,620.84	5,761.85	5,592.94	4,461.80
Revenue	10,043.69	10,743.47	8,511.19	8,241.54
Profit After Tax	607.73	456.93	357.47	1,033.67
Net Worth	3,431.34	2,363.60	1,906.67	-786.39
Reserves and Surplus	1,562.46	588.66	131.73	-1,275.74
Total Borrowing	2,005.44	1,365.22	1,804.86	3,292.98
Amount in ₹ Lakhs

Nephro Care India Limited Financial Information (Restated)

Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	2,029.85	831.11	462.93	112.84
Revenue	1,989.60	1,709.51	342.70	183.26
Profit After Tax	340.04	194.24	-0.98	8.87
Net Worth	1,392.32	243.76	49.52	1.50
Reserves and Surplus	1,332.81	193.76	-0.48	0.50
Total Borrowing		246.39	253.74	69.27
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

94.97%

85.02%

Promoter Shareholding (Post-Issue)

61.39%

P/E Ratio

27.81

55.15

Market Cap

₹171.64 Cr.

₹148.38 Cr.

ROE

20.80%%

41.57%%

ROCE

13.14%%

36.56%%

Debt/Equity

0.58

EPS

₹2.44

₹1.63

RoNW

20.80%%

24.42%%

Shares Offered

In the Ambey Laboratories IPO retail investors (RII) are offered while in Nephro Care India IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Ambey Laboratories IPO and 8,25,600 shares in Nephro Care India IPO.

	Ambey Laboratories IPO	Nephro Care India IPO
Anchor Investor Reserveration		12,38,400 shares
Market Maker Reserveration	3,12,000 shares	2,30,400 shares
QIB		8,25,600 shares
NII		6,19,200 shares
RII		14,44,800 shares
Employee		0 shares
Others
Total		31,15,200 shares

Bids Received (Subscription)

Ambey Laboratories IPO subscribed in total, whereas Nephro Care India IPO subscribed 16.84x.

	Ambey Laboratories IPO	Nephro Care India IPO
QIB (times)		0.09x
NII (times)		14.13x
Big NII (times)
Small NII (times)
RII (times)		30.20x
Employee (times)
Other (times)
Total (times)		16.84x

Compare with others

Ambey Laboratories IPO	Nephro Care India IPO
Nephro Care India IPO	Ambey Laboratories IPO
Diensten Tech IPO	Diensten Tech IPO
Visaman Global Sales IPO	Visaman Global Sales IPO
Mason Infratech IPO	Mason Infratech IPO
Petro Carbon and Chemicals IPO	Petro Carbon and Chemicals IPO
	Sylvan Plyboard IPO

Comments

Add a public comment...